WAC expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.477800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.906600E-01
Normal-vs-Stage2
1.034600E-01
Normal-vs-Stage3
2.337700E-02
Normal-vs-Stage4
6.684200E-01
Stage1-vs-Stage2
5.889200E-01
Stage1-vs-Stage3
6.535700E-02
Stage1-vs-Stage4
4.375200E-01
Stage2-vs-Stage3
1.170840E-01
Stage2-vs-Stage4
1.927150E-01
Stage3-vs-Stage4
1.534080E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.753800E-02
Normal-vs-AfricanAmerican
6.441600E-01
Normal-vs-Asian
8.925600E-02
Caucasian-vs-AfricanAmerican
1.348850E-01
Caucasian-vs-Asian
5.347400E-01
AfricanAmerican-vs-Asian
1.404800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.062990E-01
Normal-vs-Female
9.500400E-02
Male-vs-Female
9.859200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.453600E-01
Normal-vs-Age(41-60Yrs)
3.434400E-01
Normal-vs-Age(61-80Yrs)
4.523800E-02
Normal-vs-Age(81-100Yrs)
2.031800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.064200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.641800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.786600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.966100E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.939500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.881800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.313600E-02
Normal-vs-Daily Drinker
3.083800E-02
Normal-vs-Weekly Drinker
5.462100E-02
Normal-vs-Occasional Drinker
2.368600E-01
Normal-vs-Social Drinker
2.737400E-01
Non Drinker-vs-Daily Drinker
6.336600E-01
Non Drinker-vs-Weekly Drinker
9.136600E-01
Non Drinker-vs-Occasional Drinker
1.013370E-01
Non Drinker-vs-Social Drinker
3.079600E-01
Daily Drinker-vs-Weekly Drinker
7.766200E-01
Daily Drinker-vs-Occasional Drinker
6.123700E-02
Daily Drinker-vs-Social Drinker
2.102800E-01
Weekly Drinker-vs-Occasional Drinker
1.571210E-01
Weekly Drinker-vs-Social Drinker
3.794600E-01
Occasional Drinker-vs-Social Drinker
7.444400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.526300E-02
Normal-vs-Grade 2
1.612360E-02
Normal-vs-Grade 3
1.695560E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.962400E-01
Grade 1-vs-Grade 3
4.345400E-01
Grade 1-vs-Grade 4
9.526300E-02
Grade 2-vs-Grade 3
8.301800E-01
Grade 2-vs-Grade 4
1.612360E-02
Grade 3-vs-Grade 4
1.695560E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.183800E-02
Normal-vs-NonDiabetic
5.062300E-02
Diabetic-vs-NonDiabetic
8.803800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.655600E-02
Normal-vs-NoPancreatitis
6.283700E-02
Pancreatitis-vs-NoPancreatitis
9.802600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.080400E-02
Normal-vs-N1
1.057760E-01
N0-vs-N1
9.375000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.280000E-01
Normal-vs-TP53-NonMutant
3.009800E-01
TP53-Mutant-vs-TP53-NonMutant
9.938400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
